Vaccine Hesitancy in Autism Spectrum Disorder: A Systematic Review With Meta-Analyses
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2026 (SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s10803-026-07456-4
- Dergi Adı: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
- Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, Agricultural & Environmental Science Database, BIOSIS, Child Development & Adolescent Studies, CINAHL, EBSCO Education Source, Education Abstracts, Educational research abstracts (ERA), EMBASE, ERIC (Education Resources Information Center), MEDLINE, Psycinfo, Public Affairs Index, Academic Search Ultimate (EBSCO), Social Science Premium Collection (ProQuest), Biomedical Reference Collection: Corporate Edition (EBSCO), Education Collection (ProQuest), Education Source Ultimate (EBSCO), Health Research Premium Collection (ProQuest), Psychology & Behavioral Sciences Collection (EBSCO), Sociology Database (ProQuest), Sociology Source Ultimate (EBSCO)
- İstanbul Üniversitesi Adresli: Evet
Özet
Purpose This systematic review and meta-analysis examined vaccine hesitancy and related vaccination behaviours in autism spectrum disorder (ASD)-related populations. We aimed to quantify the burden of hesitancy and synthesize evidence on refusal, delay, and under-vaccination among caregivers of children with ASD and, where available, autistic adults.Methods Following PRISMA 2020 and a prospectively registered PROSPERO protocol (CRD420251154536), we searched MEDLINE/PubMed, Web of Science, EBSCO, and TR Dizin from inception to 28 September 2025. Quantitative, qualitative, and mixed-methods studies addressing vaccine hesitancy or vaccination behaviours in ASD-related populations were eligible. Narrative synthesis was undertaken across all included studies, and meta-analysis was performed where outcomes were sufficiently comparable.Results Twenty studies were included (16 quantitative, 3 qualitative, 1 mixed-methods). Among studies using a common instrument and threshold (PACV >= 50), the pooled prevalence of vaccine hesitancy among caregivers of children with ASD was 23.65% (95% CI 15.87-33.71). Compared with caregivers of neurotypical children, caregivers of children with ASD had higher odds of vaccine hesitancy or refusal (pooled OR = 2.31, 95% CI 1.66-3.22). They also had higher odds than families of children with other neurodevelopmental conditions (pooled OR = 2.23, 95% CI 1.48-3.35). Sibling-focused analyses suggested greater under-vaccination among younger siblings in ASD-affected families (pooled RR = 3.20, 95% CI 2.59-3.96). Narrative findings consistently implicated the disproven MMR-autism claim, safety concerns, and distrust.Conclusion Vaccine hesitancy and related under-vaccination appear to be disproportionately concentrated in ASD-affected families. Autism-informed counselling, explicit myth-correction by trusted clinicians, and service adaptations may improve timely vaccine uptake.